Results 261 to 270 of about 296,448 (281)

Guselkumab in Biologic-Naive Patients With Active Psoriatic Arthritis (DISCOVER-2): A Double-Blind, Randomised, Placebo-Controlled Phase 3 Trial

Lancet, The, 2020
Elizabeth Ohneck, Alice B Gottlieb, Proton Rahman   +2 more
exaly  

HIPPOCRATES: Improving Diagnosis and Outcomes in Psoriatic Arthritis

Nature Reviews Rheumatology, 2022
Stephen R. Pennington, Oliver FitzGerald
exaly  

Psoriatic Arthritis

Clinics in Rheumatic Diseases, 1983
H A, Bird, V, Wright
openaire   +2 more sources

Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis: A Randomised Trial

Lancet, The, 2000
Philip J Mease
exaly  

Ustekinumab, a Human Interleukin 12/23 Monoclonal Antibody, for Psoriatic Arthritis: Randomised, Double-Blind, Placebo-Controlled, Crossover Trial

Lancet, The, 2009
Arthur Kavanaugh, Alice B Gottlieb, Alan Menter   +2 more
exaly  

Effect of Tight Control of Inflammation in Early Psoriatic Arthritis (TICOPA): A UK Multicentre, Open-Label, Randomised Controlled Trial

Lancet, The, 2015
Sarah Brown, Philip G Conaghan, Philip Helliwell   +2 more
exaly  

Prevalence of Psoriatic Arthritis in Patients With Psoriasis: A Systematic Review and Meta-Analysis of Observational and Clinical Studies

Journal of the American Academy of Dermatology, 2019
Alexander Egeberg, Lars Erik Kristensen, Jashin J. Wu   +2 more
exaly  

Efficacy and Safety of Guselkumab in Patients With Active Psoriatic Arthritis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study

Lancet, The, 2018
Juan J Gómez-Reino, Melinda Gooderham, Kim A. Papp   +2 more
exaly  

Management of Psoriatic Arthritis in 2016: A Comparison of EULAR and GRAPPA Recommendations

Nature Reviews Rheumatology, 2016
Elizabeth Ohneck, Arthur Kavanaugh, Christopher T Ritchlin   +2 more
exaly  

Is Methotrexate Effective in Psoriatic Arthritis?

Nature Reviews Rheumatology, 2012
Philip J Mease
exaly